Authors' objectives: The National Health Committee (NHC) is undertaking a national review of Transcatheter Aortic Valve Implantation (TAVI) in New Zealand. Currently in this country the intervention is performed in the public sector on high risk surgical candidates at Auckland, Waikato and Canterbury District Health Boards (DHBs). In 2010/11, at the request of the National Health Board, Auckland DHB's Clinical Practice Committee (Auckland CPC) provided an independent evaluation of TAVI. At that time the National Service and Technology Review Advisory Committee had been discontinued and a reconfigured NHC not yet established. Based on the evidence then available, in addition to a number of recommendations around interim public funding for high risk surgical candidates, Auckland CPC also indicated that it would be necessary to further review TAVI in 12 to 18 months as more evidence became available. Recent publications could indicate a potential change in direction to the approach currently being taken to publicly funded TAVI in New Zealand, so that further review now seems both required and timely. This briefing report sets out the current situation in more detail. It reveals that recent literature is suggesting that TAVI is associated with an increased rate of stroke in high risk surgical patients when compared to surgical aortic valve replacement.

Project Status: Completed

Year Published: 2012

URL for published report: http://nhc.health.govt.nz/committee-publications/transcatheter-aortic-valve-implantation-tavi-briefing-report

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: New Zealand

Organisation Name: New Zealand National Health Committee

Contact Address: National Health Committee, PO Box 5013, 6145 Wellington New Zealand Tel: +64 4 496 2120

Contact Name: nhc_info@nhc.govt.nz

Contact Email: nhc_info@nhc.govt.nz

Copyright: New Zealand National Health Committee (NHC)